Pfizer (PFE) Tops Q1 EPS by 24c; offers guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.63 +1.22%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $0.92, $0.24 better than the analyst estimate of $0.68. Revenue for the quarter came in at $13.72 billion versus the consensus estimate of $14.09 billion.
GUIDANCE:
Pfizer sees FY2025 EPS of $2.80-$3.00, versus the consensus of $2.95. Pfizer sees FY2025 revenue of $61-64 billion, versus the consensus of $62.92 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
- UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
